BioSpace News Archive

Castlight Health, Inc. (NYSE: CSLT) will release its second quarter 2019 financial results on Tuesday, July 30, 2019, after the market closes

Pete has an extensive background in life science consulting, partnering with manufacturers on key customer insight activities to drive results across a broad range of marketing and business development initiatives.

Providertech announced today its platform interface with Epic.

Pixel by LabCorp Now Available with Phlebotomy Collection Through LabCorp’s Nationwide Patient Service Center Network

The Honourable Kirsty Duncan, Minister of Science and Sport, will announce a major investment through Genome Canada at the first ever International Wheat Congress.

The newly constructed state-of-art production facility is operated by the Liaoning Yisheng Biopharma subsidiary.

Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that Memorial Sloan Kettering Cancer Center (MSK) in New York, NY will investigate the potential use of Kazia’s investigational new drug, GDC-0084, in combination with radiotherapy in a phase I clinical trial for cancer

The novel therapeutic entity HAMLET is formed specifically when the human milk protein alpha-lactalbumin undergoes a conformational change and binds to oleic acid.

As COO Mr. Papandrea will lead operations including billing, patient support, sales and device production.

For the first time, Bayer U.S. earned an 80 in the 2019 Disability Equality Index (DEI), and was recognized as a Best Place to Work for Disability Inclusion. DEI is the most comprehensive disability inclusion assessment tool designed and embraced by both business leaders and disability advocates across the United States.